Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OME > SEC Filings for OME > Form 8-K on 6-May-2013All Recent SEC Filings

Show all filings for OMEGA PROTEIN CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for OMEGA PROTEIN CORP


6-May-2013

Results of Operations and Financial Condition


Item 2.02 Results of Operations and Financial Condition.

As previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2012, Omega Protein Corporation (the "Company") operates and reports in two segments: animal nutrition and human nutrition (plus an unallocated amount).

Set forth below is supplemental historical segment information for the Company by quarter for 2011 and 2012 (in thousands).

                                                          For the Three Months Ended
                                           March 31,      June 30,       September       December
Animal Nutrition                              2011          2011         30, 2011        31, 2011
Revenue                                    $   57,068     $  42,348     $    72,851     $    64,222
Cost of sales                                  42,269        29,339          60,989          54,495
Gross profit                                   14,799        13,009          11,862           9,727
Selling, general and administrative
expenses (including research and
development)                                      539           599             563           1,103
Charges related to U.S. Attorney
investigation                                       -             -               -             545
Other (gains) and losses                          (18 )     (26,497 )           199           1,447
Operating income                           $   14,278     $  38,907     $    11,100     $     6,632
Depreciation and amortization              $    3,733     $   3,756     $     3,801     $     3,808
Identifiable assets                        $  237,024     $ 270,816     $   275,222     $   248,318
Capital expenditures                       $    3,270     $   5,738     $     4,091     $     9,984




                                                          For the Three Months Ended
                                           March 31,      June 30,       September       December
Animal Nutrition                              2012          2012         30, 2012        31, 2012
Revenue                                    $   34,239     $  42,467     $    78,745     $    58,173
Cost of sales                                  27,098        36,782          66,218          46,490
Gross profit                                    7,141         5,685          12,527          11,683
Selling, general and administrative
expenses (including research and
development)                                      722           556             555             731
Charges related to U.S. Attorney
investigation                                     233            70           4,137           3,550
Other (gains) and losses                         (397 )      (3,385 )            30           1,117
Operating income                           $    6,583     $   8,444     $     7,805     $     6,285
Depreciation and amortization              $    3,865     $   4,018     $     4,020     $     3,956
Identifiable assets                        $  253,741     $ 263,276     $   276,969     $   266,307
Capital expenditures                       $    7,635     $   7,260     $     3,751     $     4,345




                                                           For the Three Months Ended
                                            March 31,       June 30,       September        December
Human Nutrition                               2011            2011          30, 2011        31, 2011
Revenue                                    $     3,069     $    3,969     $      3,633     $     4,583
Cost of sales                                    2,175          2,235            2,069           3,498
Gross profit                                       894          1,734            1,564           1,085
Selling, general and administrative
expenses (including research and
development)                                     1,101            340              841           1,004
Other (gains) and losses                             -              1                -               -
Operating income                           $      (207 )   $    1,393     $        723     $        81
Depreciation and amortization              $        91     $       91     $         90     $       376
Identifiable assets                        $    15,197     $   15,604     $     25,872     $    27,403
Capital expenditures                       $         -     $        -     $          -     $       566


                                                           For the Three Months Ended
                                            March 31,       June 30,       September        December
Human Nutrition                               2012            2012          30, 2012        31, 2012
Revenue                                    $     6,849     $    4,981     $      5,225     $     4,960
Cost of sales                                    5,098          3,819            4,354           3,724
Gross profit                                     1,751          1,162              871           1,236
Selling, general and administrative
expenses (including research and
development)                                       994            927              905             969
Other (gains) and losses                             -              -              129               -
Operating income                           $       757     $      235     $       (163 )   $       267
Depreciation and amortization              $       319     $      319     $        329     $       348
Identifiable assets                        $    28,344     $   27,690     $     26,422     $    27,109
Capital expenditures                       $       641     $      685     $        256     $       177




                                                           For the Three Months Ended
                                            March 31,       June 30,       September        December
Unallocated                                   2011            2011          30, 2011        31, 2011
Selling, general and administrative
expenses (including research and
development)                                     3,696          4,327            4,675           5,850
Operating income                           $    (3,696 )   $   (4,327 )   $     (4,675 )   $    (5,850 )
Depreciation and amortization              $       155     $      181     $        174     $       174
Identifiable assets                        $     2,423     $    2,367     $      2,178     $     2,109
Capital expenditures                       $       138     $        -     $         11     $        95




                                                           For the Three Months Ended
                                            March 31,       June 30,       September        December
Unallocated                                   2012            2012          30, 2012        31, 2012
Selling, general and administrative
expenses (including research and
development)                                     4,170          4,478            4,738           4,201
Operating income                           $    (4,170 )   $   (4,478 )   $     (4,738 )   $    (4,201 )
Depreciation and amortization              $       143     $      134     $        161     $       387
Identifiable assets                        $     1,975     $    1,786     $      1,624     $     1,880
Capital expenditures                       $        40     $      249     $         53     $       153


  Add OME to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OME - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.